Jean-Jacques Kiladjian: Interferon-Alpha in Polycythemia Vera Balancing Efficacy and Autoimmune Risk
Jean-Jacques Kiladjian, Head of Clinical Research Department of Inserm, Professor of Medicine at the University of Paris Cité, President of the FIM, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in HemaSphere, adding:
“Interferon-alpha is a major treatment for Polycythemia Vera, but its use requires some precautions, particularly due to its immunomodulatory properties. In this article, we review the immune-related complications associated with interferon-alpha therapy and discuss strategies for their prevention and management.
A pre-treatment evaluation is necessary, and discussion with a specialist is often helpful to determine whether interferon can be safely used and how patients should be monitored in the presence of pre-existing autoimmune disease or signs of autoimmunity.”
Title: Autoimmunity and peginterferon therapy for polycythemia vera
Authors: Etienne Rivière, Alexandre Guy, Olivier Mansier, Clémence Mediavilla, Jean-Jacques Kiladjian, Chloé James, Patrick Blanco, Estibaliz Lazaro, Jean-François Viallard

More posts featuring Jean Jacques Kiladjian on Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience